ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1907

Selection of a Candidate Instrument to Assess Flare in Osteoarthritis with Content Matching with Endorsed Domains

Fabiana Queiroga1, Marita Cross2, Lara Maxwell3, Leigh Callahan4, sam michel Cembalo5, Thomas Buttel2, Cindy Copenhaver6, Jonathan Epstein7, david Hunter8, Lauren King9, Lyn March2 and Francis Guillemin10, 1Université de Lorraine, Antibes, France, 2University of Sydney, Sydney, Australia, 3OMERACT, Ottawa, ON, Canada, 4The University of North Carolina, Chapel Hill, NC, 5OMERACT, Nancy, France, 6OMERACT, Chapel Hill, NC, 7Université de Lorraine, Nancy, France, 8Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 9Clinical Associate, Division of Rheumatology, St. Michael’s Hospital, Toronto, ON, Canada, 10Université de Lorraine, EA 4360 Apemac, Nancy, France

Meeting: ACR Convergence 2023

Keywords: Disease Activity, Measurement Instrument, OMERACT, Osteoarthritis, Patient reported outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1895–1912) Measures & Measurement of Healthcare Quality Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The Outcome Measures in Rheumatology group (OMERACT) developed methodological steps to select instrument(s) to assess content appropriateness of outcomes, as well as tools to accomplish this task. In this study we present the results obtained following these steps to select instrument(s) to assess flares in osteoarthritis, based on the associated domains

Methods: An update of a previous 2017 literature review was conducted in PubMed, Web of Science and Psych Info databases over the period from 2017 to 2021, with the primary goal of searching instruments associated with flare in knee and hip OA or their correlated characteristics. Using the OMERACT Handbook Filter 2.21, we evaluated the content of instruments included according to five core domains endorsed by OMERACT2, and then classified into three categories: “sure match with domains of flare in OA”; “uncertain match with domains of flare in OA”; and “sure not match with domains of flare in OA”. The instruments retained in the first two categories were analyzed by the experts of the working group (WG) Flares in OA, composed of patients, physicians, and researchers, in two rounds of Delphi survey using limesurvey. The goal was to identify among these five instruments which one best matches with the target domain (trust) and which one is more practical to use (feasibility). The final selection was obtained by a vote of the group.

Results: Initially 575 papers were filtered. After experts’ analysis, 59 studies were included, and 44 instruments associated with flare in OA were identified. Most were studies about pain in knee or hip OA (35%), cultural adaptation of a measure (33%) or studies investigating psychometric properties of full (16%) or short form (4%) instruments. An international panel of 26 group members participated in the Delphi surveys. In Delphi Survey Round 1, we had 15 instruments flagged by experts with green, amber and red and we proposed: reject instrument with less than 50% in red flag, classify uncertain when they received between 50 and 70% in amber flag and keep instruments that received more than 70% in green flag. Five instruments were pre-selected: ICOAP, HOOS, KOOS, OAKHQOL and Flare-OA. WOMAC was clearly not focused on flare, and we decided to substitute the full length OAKHQOL with the short form Mini-OAKHQOL. For the Delphi Round 2, we set a unique threshold of 70% to make decision. The instruments obtained at least 75% in questions about trust and feasibility,which carried them all to the last phase, it means, to vote on the instrument. Only the Flare-OA questionnaire obtained 100% of votes in favor.

Conclusion: The OMERACT Handbook Filter 2.2 has proven helpful tool for selecting an instrument. The Flare-OA questionnaire was selected as the best matching and practical instrument to assess flare in lower limb osteoarthritis. References 1. Guillemin F, Ricatte C, Barcenilla-Wong A, et al. Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group. J Rheumatol. 2019;46(9):1188-1191. doi:10.3899/jrheum.181085 2. Berton B, Maxwell L, Grosskleg S, et al. THE OMERACT HANDBOOK. Filter 2.2. The OMERACT Handbook © 2021 by OMERACT is licensed under CC BY-ND 4.0; 2021.


Disclosures: F. Queiroga: None; M. Cross: None; L. Maxwell: None; L. Callahan: None; s. Cembalo: None; T. Buttel: None; C. Copenhaver: None; J. Epstein: None; d. Hunter: None; L. King: None; L. March: None; F. Guillemin: None.

To cite this abstract in AMA style:

Queiroga F, Cross M, Maxwell L, Callahan L, Cembalo s, Buttel T, Copenhaver C, Epstein J, Hunter d, King L, March L, Guillemin F. Selection of a Candidate Instrument to Assess Flare in Osteoarthritis with Content Matching with Endorsed Domains [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/selection-of-a-candidate-instrument-to-assess-flare-in-osteoarthritis-with-content-matching-with-endorsed-domains/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/selection-of-a-candidate-instrument-to-assess-flare-in-osteoarthritis-with-content-matching-with-endorsed-domains/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology